The Effectiveness of an Adapted Mindfulness-based Cognitive Therapy for Children with Cancer

Not Applicable

• Conditions: F06.30; F06.31; Condition 1: cancer. Condition 2: anxiety. Condition 3: depression. Condition 4: somatic complaints. Condition 5: attention problems.; Mood disorder due to known physiological condition, unspecified; Anxiety disorder due to known physiological condition; Mood disorder due to known physiological condition with depressive features; Attention-deficit hyperactivity disorders; F06.4

• Registration Number: IRCT2013120614338N1
• Lead Sponsor: aurentian Universiry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Hospitalized patients were eligible to participate in the Mindfulness-Based Cognitive Therapy for Children (MBCT-C) program in addition to receiving TAU if they were (a) 11 to 13 years of age; (b) had at least average fluency in Persian; (c) had received the first diagnosis of any type of cancer except brain cancers; (d) were undergoing radiation therapy and/or chemotherapy through the hospital’s oncology division; and (e) had not received any psychological interventions or psychiatric medications in the six months preceding the study. Diagnostic inclusion criteria were: (f) a diagnosis of Autism spectrum disorder (ASD) (Diagnostic and Statistical Manual of Mental Disorders (IV) (DSM-IV (American Psychiatric Association, 2000); and (g) at least two comorbid diagnoses in any of four diagnostic categories (anxiety, depression, psychosomatic, or attention deficit disorders). Diagnoses were ascertained using the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Persian version (K-SADS-PL-P). Additionally, patients needed to be: (h) in the borderline or clinical range for internalizing problems (T-score = 60) and attention problems (T-score = 57) on at least two of four subscales of the Child Behavior Checklist (CBCL) or Youth Self-Report (YSR )(depression/anxiety, withdrawal/depression, somatic complaints, and attention problems) at the screening assessment.

Exclusion Criteria

Patients who were determined to (i) have a major cognitive dysfunction or developmental disability, or (j) was diagnosed with a terminal illness (defined as having a prognosis of fewer than six months) were excluded. Moreover, Brain cancers were excluded based on research suggesting that these may affect attention (Raghubar et al., 2017), a key outcome variable.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Internalizing and attention problems. Timepoint: Before and 4 weeks after the treatment as well as 2-month follow-up. Method of measurement: CBCL and YSR.

Secondary Outcome Measures

Name	Time	Method
More cooperation in medical treatments in participants. Timepoint: Before and after the treatment as well as at follow-up point. Method of measurement: Interviews.